Loading market data...
markets

People switching to Novo's Wegovy pill from obesity injections kept losing weight in real-world study 

CNBC
Read Full Article at CNBC →
Share:PostShare
Ad Slot — In-Article (728x90)

The data on Novo's Wegovy pill suggests that patients may not need to take weekly injections forever, but can instead opt for more convenient treatments.

This is a summary. For the full story, read the original article at CNBC.

Original source: CNBC

Ad Slot — Below Article (300x250)